GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $2.77 $4.97 Friday, 19th Apr 2024 ALDX stock ended at $3.86. This is 3.02% less than the trading day before Thursday, 18th Apr 2024. During the day the stock fluctuated 5.28% from a day low at $3.79 to a day high of $3.99.
90 days $2.71 $4.97
52 weeks $1.42 $11.97

Historical Aldeyra Therapeutics prices

Date Open High Low Close Volume
2023-10-19 $1.67 $1.75 $1.62 $1.66 1 559 898
2023-10-18 $1.80 $1.98 $1.67 $1.73 4 970 650
2023-10-17 $1.80 $1.96 $1.75 $1.84 4 909 737
2023-10-16 $1.42 $2.55 $1.42 $1.83 21 402 942
2023-10-13 $5.42 $5.47 $5.22 $5.43 478 577
2023-10-12 $5.55 $5.57 $5.32 $5.39 491 653
2023-10-11 $5.95 $5.99 $5.49 $5.53 400 708
2023-10-10 $5.79 $6.01 $5.76 $5.94 416 728
2023-10-09 $5.81 $5.85 $5.63 $5.77 301 514
2023-10-06 $5.69 $5.90 $5.68 $5.88 442 380
2023-10-05 $5.65 $5.93 $5.56 $5.82 651 424
2023-10-04 $5.84 $5.84 $5.53 $5.61 797 948
2023-10-03 $6.04 $6.05 $5.77 $5.86 557 025
2023-10-02 $6.70 $6.74 $6.00 $6.06 1 104 585
2023-09-29 $6.32 $6.74 $6.27 $6.68 2 135 339
2023-09-28 $6.12 $6.30 $6.03 $6.26 507 284
2023-09-27 $6.20 $6.30 $6.03 $6.11 457 488
2023-09-26 $6.15 $6.55 $6.13 $6.15 440 061
2023-09-25 $6.10 $6.22 $5.95 $6.15 575 581
2023-09-22 $6.19 $6.37 $6.12 $6.14 427 417
2023-09-21 $6.29 $6.36 $6.18 $6.19 519 637
2023-09-20 $6.46 $6.49 $6.32 $6.32 437 590
2023-09-19 $6.49 $6.50 $6.37 $6.44 391 552
2023-09-18 $6.50 $6.54 $6.32 $6.46 485 541
2023-09-15 $6.96 $6.96 $6.45 $6.53 878 681
Click to get the best stock tips daily for free!

About Aldeyra Therapeutics

Aldeyra Therapeutics Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical tria... ALDX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT